Latest EU Clinical investigation Guidance Considers ‘Substantial Modification’ Definition
Executive Summary
In some cases, a “substantial” change to a clinical investigation will mean having to start anew. Industry is in urgent need of clarification of the term. But does latest EU guidance help sufficiently?
You may also be interested in...
Global Medtech Guidance Tracker: April 2021
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-two guidance documents have been posted on the tracker since its last update.
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.